Intervention for erythromelalgia, a chronic pain syndrome: Comprehensive Pain Rehabilitation Center, Mayo Clinic

Archives of Dermatology

Volumn 144, Issue 12, 2008, Pages 1578-1583

  Durosaro, Olayemi ^a   Davis, Mark D P ^b   Hooten, W Michael ^b   Kerkvliet, Jennifer L ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROMELALGIA; FEMALE; HUMAN; MALE; PAIN ASSESSMENT; PRIORITY JOURNAL; REHABILITATION CARE; SHORT FORM 36; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; COMBINED MODALITY THERAPY; EMOTIONS; ERYTHROMELALGIA; FEMALE; HEALTH STATUS; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; MINNESOTA; OCCUPATIONAL THERAPY; PAIN MEASUREMENT; PHYSICAL THERAPY MODALITIES; PSYCHOTHERAPY, GROUP; QUALITY OF LIFE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 58049192833     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2008.515     Document Type: Article

References (34)

1. Schechner J. Red skin re-read. J Invest Dermatol. 2002;119(4):781-782.
2. Davis MD, O'Fallon WM, Rogers RS III, Rooke TW. Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol. 2000;136(3):330-336.
3. Davis MD, Sandroni P, Rooke TW, Low PA. Erythromelalgia: vasculopathy, neuropathy, or both? a prospective study of vascular and neurophysiologic studies in erythromelalgia. Arch Dermatol. 2003;139(10):1337-1343.
4. Sandroni P, Davis MDP, Harper CM Jr, et al. Neurophysiologic and vascular studies in erythromelalgia: a retrospective analysis. J Clin Neuromusc Dis. 1999;1(2):57-63. doi:10.1097/00131402-199912000-0001.
5. Dib-Hajj SD, Rush AM, Cummins TR, et al. Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain. 2005;128(pt 8):1847-1854.
6. Yang Y, Wang Y, Li S, et al. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet. 2004;41 (3):171-174.
7. Black JA, Dib-Hajj S, McNabola K, et al. Spinal sensory neurons express multiple sodium channel alpha-subunit mRNAs. Brain Res Mol Brain Res. 1996;43(1-2):117-131.
8. Black JA, Liu S, Tanaka M, Cummins TR, Waxman SG. Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain. Pain. 2004;108(3):237-247.
9. Cohen JS. Erythromelalgia: new theories and new therapies. J Am Acad Dermatol. 2000;43(5, pt 1):841-847.
10. Davis MD, Rooke T. Erythromelalgia. Curr Treat Options Cardiovasc Med. 2006;8(2):153-165.
11. Gatchel RJ, Okifuji A. Evidence-based scientific data documenting the treatment and cost-effectiveness of comprehensive pain programs for chronic nonmalignant pain. J Pain. 2006;7(11):779-793.
12. Hooten WM, Townsend CO, Sletten CD, Bruce BK, Rome JD. Treatment outcomes after multidisciplinary pain rehabilitation with analgesic medication withdrawal for patients with fibromyalgia. Pain Med. 2007;8(1):8-16.
13. Kerns RD, Turk DC, Rudy TE. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain. 1985;23(4):345-356.
14. Bernstein IH, Jaremko ME, Hinkley BS. On the utility of the West Haven-Yale Multidimensional Pain Inventory. Spine. 1995;20(8):956-963.
15. Rudy TE. Multiaxial Assessment of Pain: Multidimensional Pain Inventory. Computer Program User's Manual, Version 2.1. Pittsburgh, PA: University of Pittsburgh School of Medicine; 1989.
16. Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey: reliability and validity in a patient population. Med Care. 1988;26(7):724-735.
17. Ware JE Jr. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center; 1993.
18. Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36), I: conceptual framework and item selection. Med Care. 1992;30(6):473-483.
19. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36), II: psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31(3):247-263.
20. Sullivan MJL, Bishop SR, Pivik J. The Pain Catastrophizing Scale: development and validation. Psychol Assess. 1995;7(4):524-532. doi:10.1037/1040-3590.7.4.524.
21. Sullivan MJ, Thorn B, Haythornthwaite JA, et al. Theoretical perspectives on the relation between catastrophizing and pain. Clin J Pain. 2001;17(1):52-64.
22. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385-401. doi:10.1177/01462167700100306..
23. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol. 1977;106(3):203-214.
24. Geisser ME, Roth RS, Robinson ME. Assessing depression among persons with chronic pain using the Center for Epidemiological Studies-Depression Scale and the Beck Depression Inventory: a comparative analysis. Clin J Pain. 1997;13 (2):163-170.
25. Muhiddin KA, Gallen IW, Harries S, Pearce VR. The use of capsaicin cream in a case of erythromelalgia. Postgrad Med J. 1994;70(829):841-843.
26. McGraw T, Kosek P. Erythromelalgia painmanagedwith gabapentin. Anesthesiology. 1997;86(4):988-990.
27. Stone JD, Rivey MP, Allington DR. Nitroprusside treatment of erythromelalgia in an adolescent female. Ann Pharmacother. 1997;31(5):590-592.
28. Kuhnert SM, Phillips WJ, Davis MD. Lidocaine and mexiletine therapy for erythromelalgia. Arch Dermatol. 1999;135(12):1447-1449.
29. Kandel EI. Stereotactic surgery of erythromelalgia. Stereotact Funct Neurosurg. 1990;54-55:96-100.
30. Putt AM. Erythromelalgia: a case for biofeedback. Nurs Clin North Am. 1978;13 (4):625-630.
31. Rome JD, Townsend CO, Bruce BK, Sletten CD, Luedtke CA, Hodgson JE. Chronic noncancer pain rehabilitation with opioid withdrawal: comparison of treatment outcomes based on opioid use status at admission. Mayo Clin Proc. 2004;79(6):759-768.
32. Large R, Peters J. A critical appraisal of outcome of multidisciplinary pain clinic treatments. In: Bond MR, Charlton JE, Woolf CJ, eds. Proceedings of the VIth World Congress on Pain. Amsterdam, the Netherlands: Elsevier Science Publishers BV; 1991:417-427.
33. Guzmán J, Esmail R, Karjalainen K, Malmivaara A, Irvin E, Bombardier C. Multidisciplinary rehabilitation for chronic low back pain: systematic review. BMJ. 2001;322(7301):1511-1516.
34. Flor H, Fydrich T, Turk DC. Efficacy of multidisciplinary pain treatment centers: a meta-analytic review. Pain. 1992;49(2):221-230.